NEW YORK (GenomeWeb News) – Accelr8 said today that it has begun a private sale of equity to qualified investors. The company first announced the equity offer following its annual shareholders' meeting on Dec. 16.

Accler8 also provided updates on several recent corporate events, including that of a "going concern" statement by its auditors attributed to recurring losses.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biologists turn to environmental DNA sampling to determine whether elusive or invasive species are shedding DNA in a given area.

Rob Knight writes at Scientific American that microbiome studies are about to break out of the laboratory.

Harold Varmus, the director of the National Cancer Institute, has announced that he is stepping down after nearly five years.

In Nature this week: omic analysis of permafrost microbes, hookworm genome, and more.